What is the clinical evidence from this study?

Study design: Letter. Population: Chronic heart failure. Intervention: Loop diuretic dose reduction.

What question did this study set out to answer?

To evaluate clinical and renal outcomes associated with loop diuretic dosing and dose reduction strategies in patients with stable chronic heart failure.

August 5, 2016European Journal of Heart FailureOpen Access

Dosing of Loop Diuretics in Chronic Heart Failure: It’s Time for Evidence

View Full Paper

Ask AI

Bookmark

Key result

Systematic reduction of loop diuretic doses in euvolemic patients with chronic heart failure requires further prospective randomized studies to confirm improved clinical outcomes.

Design

Editorial

Authors

CKChris J. KapeliosNational and Kapodistrian University of Athens KMKonstantinos MalliarasNational and Kapodistrian University of Athens JNJohn N. NanasHeart Failure & Transplant

Discussion

Member takes

Implication

This editorial highlights the need for prospective randomized studies to determine if systematic reduction of loop diuretic doses in euvolaemic heart failure patients improves clinical outcomes.

Key Points

To evaluate clinical and renal outcomes associated with loop diuretic dosing and dose reduction strategies in patients with stable chronic heart failure.
Critically reviewed observational and meta-analytic evidence evaluating loop diuretic dosing, withdrawal, and renal impairment in chronic heart failure.
Synthesized findings from two prospective trials investigating furosemide dose reduction in stable heart failure with reduced ejection fraction (N=32 and N=40).
In a prospective trial of 32 stable patients, reducing furosemide by 50% was safe and resulted in a 19% increase in glomerular filtration rate among patients with baseline renal impairment (<60 ml/min/1.73m²).
In a randomized trial of 40 patients on high baseline furosemide (≥120 mg daily), reducing to one-third dose was maintained in 95% of participants and yielded significantly higher 1- and 2-year survival free from heart failure hospitalization or cardiac death.
Patients maintained on high diuretic doses experienced worsening of renal function significantly more often than those randomized to reduced doses.

PICO

Population

Chronic heart failure

Intervention / Comparator

Loop diuretic dose reduction

This editorial highlights the need for prospective randomized studies to determine if systematic reduction of loop diuretic doses in euvolaemic heart failure patients improves clinical outcomes.

Cite This Study

Kapelios et al. (2016) conducted a letter in Chronic heart failure. Loop diuretic dose reduction was evaluated. Systematic reduction of loop diuretic doses in euvolemic patients with chronic heart failure requires further prospective randomized studies to confirm improved clinical outcomes.

synapsesocial.com/papers/6a7f097de26ba2240a9a1fdc https://doi.org/10.1002/ejhf.619

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Implication

This editorial highlights the need for prospective randomized studies to determine if systematic reduction of loop diuretic doses in euvolaemic heart failure patients improves clinical outcomes.

Dosing of Loop Diuretics in Chronic Heart Failure: It’s Time for Evidence

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Topics

Dosing of Loop Diuretics in Chronic Heart Failure: It’s Time for Evidence

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Also Consider

Topics

Also Consider